Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1989 Apr;96(4):864–871. doi: 10.1111/j.1476-5381.1989.tb11896.x

8-OH-DPAT, flesinoxan and guanfacine: systemic and regional haemodynamic effects of centrally acting antihypertensive agents in anaesthetized rabbits.

R P Hof 1, J R Fozard 1
PMCID: PMC1854428  PMID: 2568144

Abstract

1. 8-Hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) and flesinoxan, agents which show high affinity and selectivity for 5-HT1A receptors, were administered intravenously in doses of 0.003 to 0.1 and 0.01 to 0.3 mg kg-1 respectively to 5 rabbits each. Their effects were compared with those of the centrally acting agent and alpha 2-adrenoceptor agonist, guanfacine, 0.01-0.3 mg kg-1, administered to a group of 5 rabbits. Five further rabbits were used as controls and treated with the vehicle of the active agents. 2. Both flesinoxan and 8-OH-DPAT induced similar systemic and regional haemodynamic changes. Both lowered mean arterial pressure and heart rate. The principal blood pressure lowering mechanism was vasodilatation; cardiac output changed minimally despite the falls in heart rate and myocardial contractile force. 3. With guanfacine the maximal fall of blood pressure was comparable to that obtained with the 5-HT1A receptor ligands; however, in contrast to the latter, the dose-response curve was U-shaped, the highest dose eliciting a pressor effect with reversal of the vasodilatation. 4. Widespread peripheral vasodilatation was found with all the agents in the splanchnic circulation and also in the brain and skeletal muscle. A weak tendency towards vasodilatation was found in the kidneys where the dose-response curve was bell-shaped for guanfacine. 5. This spectrum of activity is different from that of peripheral vasodilators, such as calcium antagonists, potassium channel activating agents or hydralazine; it is, however, consistent with the putative mechanism of action of these compounds to reduce peripheral sympathetic tone by a central mechanism of action.

Full text

PDF
864

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bolt G. R., Saxena P. R. Acute systemic and regional hemodynamic effects of felodipine, a new calcium antagonist, in conscious renal hypertensive rabbits. J Cardiovasc Pharmacol. 1984 Jul-Aug;6(4):707–712. doi: 10.1097/00005344-198407000-00025. [DOI] [PubMed] [Google Scholar]
  2. Bradley P. B., Engel G., Feniuk W., Fozard J. R., Humphrey P. P., Middlemiss D. N., Mylecharane E. J., Richardson B. P., Saxena P. R. Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology. 1986 Jun;25(6):563–576. doi: 10.1016/0028-3908(86)90207-8. [DOI] [PubMed] [Google Scholar]
  3. Cook N. S., Hof R. P. Cardiovascular effects of apamin and BRL 34915 in rats and rabbits. Br J Pharmacol. 1988 Jan;93(1):121–131. doi: 10.1111/j.1476-5381.1988.tb11412.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dabire H., Cherqui C., Fournier B., Schmitt H. Comparison of effects of some 5-HT1 agonists on blood pressure and heart rate of normotensive anaesthetized rats. Eur J Pharmacol. 1987 Aug 21;140(3):259–266. doi: 10.1016/0014-2999(87)90282-2. [DOI] [PubMed] [Google Scholar]
  5. Di Francesco G. F., Petty M. A., Fozard J. R. Antihypertensive effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in conscious dogs. Eur J Pharmacol. 1988 Mar 1;147(2):287–290. doi: 10.1016/0014-2999(88)90789-3. [DOI] [PubMed] [Google Scholar]
  6. Doods H. N., Boddeke H. W., Kalkman H. O., Hoyer D., Mathy M. J., van Zwieten P. A. Central 5-HT1A receptors and the mechanism of the central hypotensive effect of (+)8-OH-DPAT, DP-5-CT, R28935, and urapidil. J Cardiovasc Pharmacol. 1988 Apr;11(4):432–437. doi: 10.1097/00005344-198804000-00008. [DOI] [PubMed] [Google Scholar]
  7. Fozard J. R., Mir A. K., Middlemiss D. N. Cardiovascular response to 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in the rat: site of action and pharmacological analysis. J Cardiovasc Pharmacol. 1987 Mar;9(3):328–347. doi: 10.1097/00005344-198703000-00010. [DOI] [PubMed] [Google Scholar]
  8. Gradin K., Pettersson A., Hedner T., Persson B. Acute administration of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), a selective 5-HT-receptor agonist, causes a biphasic blood pressure response and a bradycardia in the normotensive Sprague-Dawley rat and in the spontaneously hypertensive rat. J Neural Transm. 1985;62(3-4):305–319. doi: 10.1007/BF01252244. [DOI] [PubMed] [Google Scholar]
  9. Hof R. P., Hof A. Effects of bromocriptine on the heart and the peripheral circulation of anesthetized cats. J Cardiovasc Pharmacol. 1984 Jan-Feb;6(1):68–75. [PubMed] [Google Scholar]
  10. Hof R. P., Hof A., Salzmann R., Wyler F. Trapping and intramyocardial distribution of microspheres with different diameters in cat and rabbit hearts in vitro. Basic Res Cardiol. 1981 Nov-Dec;76(6):630–638. doi: 10.1007/BF01908053. [DOI] [PubMed] [Google Scholar]
  11. Hof R. P., Hof A. Very small microspheres are useful for the determination of cardiac output but not organ blood flow in conscious rabbits. Experientia. 1981 Apr 15;37(4):438–439. doi: 10.1007/BF01959909. [DOI] [PubMed] [Google Scholar]
  12. Hof R. P. Modification of vasopressin- and angiotensin II- induced changes by calcium antagonists in the peripheral circulation of anaesthetized rabbits. Br J Pharmacol. 1985 May;85(1):75–87. doi: 10.1111/j.1476-5381.1985.tb08833.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hof R. P., Wyler F., Stalder G. Validation studies for the use of the microsphere method in cats and young minipigs. Basic Res Cardiol. 1980 Nov-Dec;75(6):747–756. doi: 10.1007/BF01910452. [DOI] [PubMed] [Google Scholar]
  14. Martin G. E., Lis E. V., Jr Hypotensive action of 8-hydroxy-2-(di-N-propylamino)tetralin (8-OH-DPAT) in spontaneously hypertensive rats. Arch Int Pharmacodyn Ther. 1985 Feb;273(2):251–261. [PubMed] [Google Scholar]
  15. Middlemiss D. N., Fozard J. R. 8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition site. Eur J Pharmacol. 1983 May 20;90(1):151–153. doi: 10.1016/0014-2999(83)90230-3. [DOI] [PubMed] [Google Scholar]
  16. Mir A. K., Hibert M., Tricklebank M. D., Middlemiss D. N., Kidd E. J., Fozard J. R. MDL 72832: a potent and stereoselective ligand at central and peripheral 5-HT1A receptors. Eur J Pharmacol. 1988 Apr 27;149(1-2):107–120. doi: 10.1016/0014-2999(88)90048-9. [DOI] [PubMed] [Google Scholar]
  17. Ramage A. G., Fozard J. R. Evidence that the putative 5-HT1A receptor agonists, 8-OH-DPAT and ipsapirone, have a central hypotensive action that differs from that of clonidine in anaesthetised cats. Eur J Pharmacol. 1987 Jun 19;138(2):179–191. doi: 10.1016/0014-2999(87)90431-6. [DOI] [PubMed] [Google Scholar]
  18. Ramage A. G., Wouters W., Bevan P. Evidence that the novel antihypertensive agent, flesinoxan, causes differential sympathoinhibition and also increases vagal tone by a central action. Eur J Pharmacol. 1988 Jul 14;151(3):373–379. doi: 10.1016/0014-2999(88)90533-x. [DOI] [PubMed] [Google Scholar]
  19. Reid J. L. Alpha-adrenergic receptors and blood pressure control. Am J Cardiol. 1986 Mar 28;57(9):6E–12E. doi: 10.1016/0002-9149(86)90716-2. [DOI] [PubMed] [Google Scholar]
  20. Rudolph A. M., Heymann M. A. The circulation of the fetus in utero. Methods for studying distribution of blood flow, cardiac output and organ blood flow. Circ Res. 1967 Aug;21(2):163–184. doi: 10.1161/01.res.21.2.163. [DOI] [PubMed] [Google Scholar]
  21. Scholtysik G. Animal pharmacology of guanfacine. Am J Cardiol. 1986 Mar 28;57(9):13E–17E. doi: 10.1016/0002-9149(86)90717-4. [DOI] [PubMed] [Google Scholar]
  22. Schosser R., Arfors K. E., Messmer K. MIC-II - a program for the determination of cardiac output, arterio-venous shunt and regional blood flow using the radioactive microsphere method. Comput Programs Biomed. 1979 Jan;9(1):19–38. doi: 10.1016/0010-468x(79)90014-x. [DOI] [PubMed] [Google Scholar]
  23. Timmermans P. B., van Zwieten P. A. Mini-review. The postsynaptic alpha 2-adrenoreceptor. J Auton Pharmacol. 1981 Mar;1(2):171–183. doi: 10.1111/j.1474-8673.1981.tb00509.x. [DOI] [PubMed] [Google Scholar]
  24. Verdouw P. D., Jennewein H. M., Heiligers J., Duncker D. J., Saxena P. R. Redistribution of carotid artery blood flow by 5-HT: effects of the 5-HT2 receptor antagonists ketanserin and Wal 1307. Eur J Pharmacol. 1984 Jul 20;102(3-4):499–509. doi: 10.1016/0014-2999(84)90571-5. [DOI] [PubMed] [Google Scholar]
  25. Wouters W., Tulp M. T., Bevan P. Flesinoxan lowers blood pressure and heart rate in cats via 5-HT1A receptors. Eur J Pharmacol. 1988 May 10;149(3):213–223. doi: 10.1016/0014-2999(88)90651-6. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES